These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3436054)

  • 1. Primary hyperparathyroidism and hyperuricaemia are associated but not correlated with indicators of bone turnover.
    Broulik PD; Stĕpán JJ; Pacovský V
    Clin Chim Acta; 1987 Dec; 170(2-3):195-200. PubMed ID: 3436054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The activity of the bone isoenzyme of serum alkaline phosphatase and urinary hydroxyproline excretion in premenopausal and postmenopausal women with primary hyperparathyroidism.
    Broulik PD; Stĕpán J; Pacovský V
    Exp Clin Endocrinol; 1984 May; 83(3):315-9. PubMed ID: 6540700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between mass of parathyroid adenoma and biochemical indicators of bone turnover in patients with primary hyperparathyroidism.
    Broulík PD; Stĕpán JJ; Hradec E; Marek J; Pacovský V
    Exp Clin Endocrinol; 1986 Dec; 88(3):360-4. PubMed ID: 3556419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum osteocalcin levels and bone alkaline phosphatase isoenzyme after oophorectomy and in primary hyperparathyroidism.
    Stĕpán JJ; Presl J; Broulík P; Pacovský V
    J Clin Endocrinol Metab; 1987 May; 64(5):1079-82. PubMed ID: 3031119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary hydroxyproline concentration in primary hyperparathyroidism with and without renal stones.
    Sommer-Tsilenis E
    Eur Urol; 1977; 3(4):231-6. PubMed ID: 913450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone alkaline phosphatase isoenzyme and urinary hydroxyproline in healthy subjects, patients with osteolytic metastases, and patients with primary hyperparathyroidism.
    Stĕpán JJ; Mikulecký M; Bek V; Broulík P; Pacovský V
    Neoplasma; 1989; 36(4):495-501. PubMed ID: 2770935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperuricemia and renal handling of urate in primary hyperparathyroidism.
    Pepersack T; Jabbour N; Fuss M; Karmali R; Van Geertruyden J; Corvilain J
    Nephron; 1989; 53(4):349-52. PubMed ID: 2601802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease.
    Garnero P; Delmas PD
    J Clin Endocrinol Metab; 1993 Oct; 77(4):1046-53. PubMed ID: 8104954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fenofibrate enhances urate reduction in men treated with allopurinol for hyperuricaemia and gout.
    Feher MD; Hepburn AL; Hogarth MB; Ball SG; Kaye SA
    Rheumatology (Oxford); 2003 Feb; 42(2):321-5. PubMed ID: 12595630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urate and arteriosclerosis in primary hyperparathyroidism.
    Westerdahl J; Valdemarsson S; Lindblom P; Bergenfelz A
    Clin Endocrinol (Oxf); 2001 Jun; 54(6):805-11. PubMed ID: 11422116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal handling of urate in two patients with hyperuricemia and primary hyperparathyroidism.
    Hisatome I; Ishimura M; Sasaki N; Yamakawa M; Kosaka H; Tanaka Y; Kouchi T; Mitani Y; Yoshida A; Kotake H
    Intern Med; 1992 Jun; 31(6):807-11. PubMed ID: 1392185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone isoenzyme of serum alkaline phosphatase and urinary hydroxyproline excretion in thyrotoxicosis.
    Broulik PD; Stĕpán JJ; Límanová Z; Pacovský V
    Endocrinol Exp; 1985 Sep; 19(3):165-9. PubMed ID: 3876205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urate metabolism in primary hyperparathyroidism.
    Ljunghall S; Akerström G
    Urol Int; 1982; 37(2):73-8. PubMed ID: 7112764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of bisphosphonate therapy and parathyroidectomy on the urinary excretion of galactosylhydroxylysine in primary hyperparathyroidism.
    LoCascio V; Braga V; Bertoldo F; Bettica P; Pasini AF; Stefani L; Moro L
    Clin Endocrinol (Oxf); 1994 Jul; 41(1):47-51. PubMed ID: 8050131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Urinary excretion of hydroxyproline in parathyroid disorders, with special reference to its changes before and after parathyroidectomy in primary hyperparathyroidism].
    Yumita S
    Nihon Naibunpi Gakkai Zasshi; 1983 Jul; 59(7):949-61. PubMed ID: 6685063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of bone turnover evaluated by 47Ca-kinetics. Efficiency of serum bone gamma-carboxyglutamic acid-containing protein, serum alkaline phosphatase, and urinary hydroxyproline excretion.
    Charles P; Poser JW; Mosekilde L; Jensen FT
    J Clin Invest; 1985 Dec; 76(6):2254-8. PubMed ID: 3878367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bone isoenzyme of serum alkaline phosphatase and the excretion of hydroxyproline in bone diseases].
    Stĕpán J; Pacovský V; Horn V; Silinková-Málková E; Konopásek B; Formánková J; Vokrouhlická O; Hrba J; Marek J
    Vnitr Lek; 1977 Jun; 23(7):655-63. PubMed ID: 898700
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum urate in subjects with hypercalcaemic hyperparathyroidism.
    Christensson T
    Clin Chim Acta; 1977 Nov; 80(3):529-33. PubMed ID: 912919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of urate-lowering therapies on renal handling of uric acid.
    Ma L; Wei L; Chen H; Zhang Z; Yu Q; Ji Z; Jiang L
    Clin Rheumatol; 2016 Jan; 35(1):133-41. PubMed ID: 25373449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum urate concentrations in homozygous sickle cell disease.
    De Ceulaer K; Morgan AG; Choo-Kang E; Wilson WA; Serjeant GR
    J Clin Pathol; 1981 Sep; 34(9):965-9. PubMed ID: 7276221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.